AM
Akhyansh Mohapatra
About Akhyansh Mohapatra
Data last updated:
Akhyansh Mohapatra is a Director at 0Xytocin Ventures Private Limited (since 2022). The companies operate in Information Technology. 0Xytocin Ventures Private Limited reported revenue of ₹37 Lakh (FY 2025). Earlier, Akhyansh Mohapatra was a Director at Fastnext Education Private Limited (from 2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 0Xytocin Ventures Private Limited U72900TG2022PTC159209 | Director | 31 Jan 2022 | 2022 | ₹37 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Fastnext Education Private Limited U74999OR2016PTC025379 | Director | 15 Jun 2016 | 2016 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Akhyansh Mohapatra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Atul Shreyas Pannala | 09486286 | 0Xytocin Ventures Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Akhyansh Mohapatra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Akhyansh Mohapatra
Akhyansh Mohapatra currently holds 1 directorship: 0Xytocin Ventures Private Limited (Director, since 31 Jan 2022, revenue ₹37 Lakh (FY 2025)).
Akhyansh Mohapatra was first appointed on 15 Jun 2016 as Director at Fastnext Education Private Limited. The most recent appointment on record is 31 Jan 2022 at 0Xytocin Ventures Private Limited.
Akhyansh Mohapatra held 1 earlier board appointment: Fastnext Education Private Limited (Director, from 15 Jun 2016).
The current boards of Akhyansh Mohapatra's companies include Atul Shreyas Pannala (0Xytocin Ventures Private Limited).